Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Baricitinib is effective and safe for treating severe alopecia areata.

Baricitinib is more effective than methotrexate for severe alopecia areata.

BD 1/4 dilution is the best for treating localized alopecia areata in adults.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

The FDA approved a new Pfizer drug for hair loss in teens.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

Bimatoprost and clobetasol are both effective for scalp hair loss, but bimatoprost works faster, has fewer side effects, and grows more colored hair.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

The patch effectively promotes hair growth for alopecia areata without pain.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Oral pulse steroids reduce TNF-α levels, improving alopecia areata.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Etanercept improved arthritis and psoriasis but caused hair loss, which healed after switching to sulfasalazine.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

BMS-470539 reduces skin fibrosis and inflammation.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Sirolimus effectively reduces lesions and improves quality of life in Blue Rubber Bleb Nevus Syndrome with manageable side effects.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.